Submission Details
| 510(k) Number | K212365 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 30, 2021 |
| Decision Date | March 01, 2022 |
| Days to Decision | 214 days |
| Submission Type | Traditional |
| Review Panel | Radiology (RA) |
| Summary | Summary PDF |
K212365 is an FDA 510(k) clearance for the BoneView, a Radiological Computer Assisted Detection/diagnosis Software For Fracture (Class II — Special Controls, product code QBS), submitted by Gleamer (Saint Mand?, FR). The FDA issued a Cleared decision on March 1, 2022, 214 days after receiving the submission on July 30, 2021. This device falls under the Radiology review panel. Regulated under 21 CFR 892.2090.
| 510(k) Number | K212365 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 30, 2021 |
| Decision Date | March 01, 2022 |
| Days to Decision | 214 days |
| Submission Type | Traditional |
| Review Panel | Radiology (RA) |
| Summary | Summary PDF |
| Product Code | QBS — Radiological Computer Assisted Detection/diagnosis Software For Fracture |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 892.2090 |
| Definition | A Radiological Computer Assisted Detection And Diagnostic Software For Suspected Fracture Is An Image Processing Device Intended To Aid In The Detection, Localization, And/or Characterization Of Fracture On Acquired Medical Images (e.g. Radiography, Mr, Ct). The Device Detects, Identifies And/or Characterizes Fracture Based On Features Or Information Extracted From Images, And May Provide Information About The Presence, Location, And/or Characteristics Of The Fracture To The User. Primary Diagnostic And Patient Management Decisions Are Made By The Clinical User. |